
Tag: treatment options
- ALK Experts
- ALK International
- ALK Positive News
- Clinical Trials
- Government
- Living with ALK+
- Nutrition
- Patient & Care Partner Stories
- Powered By Patients
- Recipes
- Research
-

ALK Chat
Join us where we discuss everything “ALK”.
-

Dr. Shirish Gadgeel
Join us for ALKtALK with Shirish Gadgeel, MD, and gain a deeper understanding of the essential role chemotherapy plays in ALK-positive cancer care.
-
Brain Metastasis Radiation Options
Radiation Options to Treat Brain Metastasis: Quick Review of WBR, SRS, and SFRT Nieder et. al. wrote an easy to understand paper on the management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous. The authors used data from 17 real patients to request recommendations…
-
Lung Cancer Research Round Up: Brain Metastasis Radiation Options
Radiation Options to Treat Brain Metastasis: Quick Review of WBR, SRS, and SFRT Nieder et. al. wrote an easy to understand paper on the management of patients with brain metastases from non-small cell lung cancer and adverse prognostic features: multi-national radiation treatment recommendations are heterogeneous. The authors used data from 17 real patients to request…
-
Case Study: successful re-use of Brigatinib after Lorlatinib
Case study: Successful re-use of Brigatinib after Lorlatinib The patient in this case study was diagnosed with ALK-positive lung cancer in 2005 and had disease progression on several occasions. Chemotherapy and radiation were used to treat the first two local progressions to the brain and spinal cord. In 2012, the patient was prescribed Crizotinib for…
-
Free Second Opinion Program gives patients worldwide expert access
ALK POSITIVE SECOND OPINION PROGRAM Designed to Improve Patient Outcomes and Reduce Anxiety This unique program was conceived by our generous ALK Positive member, Jim Peard. Jim was deeply concerned that some ALK Positive members did not have access to a quality care team to guide treatment. The Medical and Pharmaceutical Advocacy Committee of ALK…
-
July 2019 Lung Cancer Research Updates
We are in a golden age of lung cancer research, but it can be hard to keep up with all the findings. Our ALK Positive newsletter volunteers have put together this list of some of the recent research being done on lung cancer, with a focus on ALK-positive lung cancer. Topic: Effectiveness of Lorlatinib and…
ALK+ Newsletter Signup
Sign up for our email newsletter to stay on top of the latest information, resources and events.
